Efficacy , safety and patient-reported outcomes of ledipasvir / sofosbuvir in NS 3 / 4 A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis ( ANRS HC 31 SOFTRIH study )

E Rosenthal,C Fougerou-Leurent,A Renault, MP Carrieri,F Marcellin,R Garraffo,E Teicher,H Aumaitre,K Lacombe,F Bailly,E Billaud,S Chevaliez, S Dominguez,MA Valantin,J Reynes,A Naqvi,L Cotte, S Metivier,V Leroy,M Dupon,T Allegre,P De Truchis,V Jeantils,J Chas,D Salmon-Ceron,P Morlat, L Alric,PM Girard,I Poizot-Martin, E Le Pabic, C Tual

semanticscholar（2019）

Cited 9|Views0

No score

Abstract

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers. L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés. Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study) E. Rosenthal, C Fougerou-Leurent, A. Renault, Mp. Carrieri, F. Marcellin, R Garraffo, E. Teicher, H Aumaitre, K. Lacombe, F. Bailly, et al.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined